Medtronic (NYSE:MDT) will host an analyst and investor briefing to provide an update on its Vascular business during the Transcatheter Cardiovascular Therapeutics (TCT) Conference on Tuesday, October 24, 2006 in Washington D.C. from 2:30-4 p.m. The briefing will include a review of the Endeavor drug-eluting stent program with remarks from members of Medtronic senior management.
